Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine March 2010, 51 (3) 11A-12A;
  • Article
  • Info & Metrics
  • PDF
Loading

Clinical multimodality imaging: Pichler and colleagues offer a focus on PET/MRI instrumentation as the next generation of clinical molecular imaging, including technical evolution and the range of potential applications.
Page 333

Figure

Monte Carlo method: Bolch provides a brief history and perspective on nuclear medicine uses of the Monte Carlo method, a class of computational algorithms that rely on repeated random samplings to compute physical quantities.
Page 337

18F-FLT PET with CTLA4 blockade: Ribas and colleagues evaluate the role of whole-body molecular imaging in patients with metastatic melanoma receiving tremelimumab, a cytotoxic T-lymphocyte–associated antigen 4–blocking antibody.
Page 340

Figure

18F-FDG uptake in normal breast: Mavi and colleagues investigate whether and how age, menopausal state, and tissue density are related to 18F-FDG uptake in normal glandular breast tissue.
Page 347

Figure

Predictive PET in NETs: Campana and colleagues explore the use of standardized uptake values from 68Ga-DOTANOC PET imaging as accurate noninvasive markers for disease prognosis in patients with neuroendocrine tumors.
Page 353

PET and surgical staging in cervical cancer: Kang and colleagues report on a metaanalysis of the diagnostic performance of 18F-FDG PET in detecting paraaortic lymph node metastasis in patients with cervical cancer.
Page 360

Arterial wall toxicity in NHL RIT: Hobbs and colleagues look at absorbed doses to the arterial wall in patients undergoing radioimmunotherapy for non-Hodgkin lymphoma to assess the potential for delayed toxicity.
Page 368

Figure

Paraaortic sentinel node localization: Vermeeren and colleagues describe and evaluate preoperative SPECT/CT for lymphatic mapping and a portable γ-camera for intraoperative radioguidance in patients with paraaortic sentinel nodes.
Page 376

Figure

Salvage therapy with 177Lu-octreotate: van Essen and colleagues detail the effects of additional therapy with this radiolabeled somatostatin analog in patients with progressive gastroenteropancreatic or bronchial neuroendocrine tumors who had benefited from previous therapeutic cycles.
Page 383

99mTc(CO)3(NTA) renal tracer: Taylor and colleagues compare the pharmacokinetics of this tricarbonyl core agent with those of 131I-ortho-iodohippuran, the clinical gold standard for measurement of effective renal plasma flow, in healthy volunteers.
Page 391

90Y-DOTATOC treatment of glioblastoma: Heute and colleagues report on the use of this somatostatin receptor radiopharmaceutical in the treatment of patients with high-grade malignant gliomas.
Page 397

Figure

Cost-effectiveness of PET and PET/CT: Buck and colleagues provide an educational overview and evaluation of methodologies for cost-effectiveness studies of PET and PET/CT in oncology.
Page 401

Endocardial versus epicardial cell injection: Mitchell and colleagues compare the cell retention and clearance kinetics of subepicardial and subendocardial techniques for stem cell delivery to recently infarcted myocardium.
Page 413

Figure

Enhanced melanoma uptake: Guo and colleagues examine the effect of the ring size of the radiolabeled lactam bridge–cyclized α-melanocyte–stimulating hormone peptide on its melanoma-targeting properties and discuss the implications for imaging and treatment.
Page 418

Figure

Targeting prostate cancer cells: He and colleagues evaluate the tumor-targeting capabilities of a radiolabeled internalizing human antibody fragment to provide high contrast in a mouse model of human prostate carcinoma.
Page 427

Knottin peptide-based ultrasound agent: Willmann and colleagues describe a new class of targeting ligands for contrast-enhanced ultrasound imaging of tumor angiogenesis using microbubbles conjugated to integrin-binding knottin peptides.
Page 433

Benzamide PET of melanoma: Denoyer and colleagues evaluate the novel melanin probe 118F-MEL050 for PET imaging of primary and metastatic melanoma using murine models.
Page 441

Figure

68Ge calibration methodology: Zimmerman and Cessna describe a technique for calibrating 68Ge radioactivity content in a commercially available source for activity calibrators in a way that is traceable to the national standard and extend this approach to 18F calibration.
Page 448

Labeling octreotide with 18F: Laverman and colleagues present a 2-step, 1-pot method for rapid and efficient labeling of peptides with 18F.
Page 454

Figure

Monte Carlo cellular dosimetry: Cai and colleagues compare Monte Carlo N-particle 111In self- and cross-doses to breast cancer cell nuclei with doses calculated by other methods and determine whether Monte Carlo results can predict cell survival.
Page 462

Animal models for dose assessment: Keenan and colleagues describe a series of anatomically realistic mouse and rat whole-body phantoms and use these models to facilitate dose calculations in various rodent species.
Page 471

Figure

111In-NLS-trastuzumab radiosensitization: Costantini and colleagues elucidate the mechanisms by which methotrexate radiosensitizes HER2-positive human breast cancer cells to the 111In-trastuzumab modified with nuclear-localization sequence peptides and determine the potential sensitizing effects of paclitaxel and doxorubicin when combined with this radiopharmaceutical.
Page 477

Figure

Improving anti-CD66 mAb RIT: Kletting and colleagues review the development of a physiologically based pharmacokinetic model capable of describing biodistribution and extrapolating between different doses of anti-CD66 monoclonal antibody in radioimmunotherapy.
Page 484

ON THE COVER

Monte Carlo N-particle simulation has been shown to compare well with 2 analytic methods in the calculation of subcellular S values. The radii of cells and nuclei have a profound effect on S values and may vary considerably. The cell and nucleus diameters of 6 commonly used breast cancer cell lines have been measured and reported for the first time.

See page 467.

Figure
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (3)
Journal of Nuclear Medicine
Vol. 51, Issue 3
March 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Mar 2010, 51 (3) 11A-12A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Mar 2010, 51 (3) 11A-12A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications
  • The Monte Carlo Method in Nuclear Medicine: Current Uses and Future Potential
  • Imaging of CTLA4 Blockade–Induced Cell Replication with 18F-FLT PET in Patients with Advanced Melanoma Treated with Tremelimumab
  • The Effect of Age, Menopausal State, and Breast Density on 18F-FDG Uptake in Normal Glandular Breast Tissue
  • Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
  • Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis
  • Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy
  • Paraaortic Sentinel Lymph Nodes: Toward Optimal Detection and Intraoperative Localization Using SPECT/CT and Intraoperative Real-Time Imaging
  • Salvage Therapy with 177Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors
  • 99mTc(CO)3(NTA): A 99mTc Renal Tracer with Pharmacokinetic Properties Comparable to Those of 131I-OIH in Healthy Volunteers
  • Response of Recurrent High-Grade Glioma to Treatment with 90Y-DOTATOC
  • Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
  • Comparison of Initial Cell Retention and Clearance Kinetics After Subendocardial or Subepicardial Injections of Endothelial Progenitor Cells in a Canine Myocardial Infarction Model
  • Reduction of the Ring Size of Radiolabeled Lactam Bridge–Cyclized α-MSH Peptide, Resulting in Enhanced Melanoma Uptake
  • Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment
  • Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides
  • High-Contrast PET of Melanoma Using 18F-MEL050, a Selective Probe for Melanin with Predominantly Renal Clearance
  • Development of a Traceable Calibration Methodology for Solid 68Ge/68Ga Sources Used as a Calibration Surrogate for 18F in Radionuclide Activity Calibrators
  • A Novel Facile Method of Labeling Octreotide with 18F-Fluorine
  • Cellular Dosimetry of 111In Using Monte Carlo N-Particle Computer Code: Comparison with Analytic Methods and Correlation with In Vitro Cytotoxicity
  • RADAR Realistic Animal Model Series for Dose Assessment
  • Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2-Amplified Human Breast Cancer Cells to the Auger Electron–Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab
  • Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire